<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-109676</identifier>
<setSpec>1887-8571</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Positive assessment of drugs: 2nd quarter 2012</dc:title>
<dc:description xml:lang="en">The drugs assessed by the Spanish Agency for Medicines and Health Products made public in the second quarter of 2012, and con-sidered of interest to the healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product (AU)</dc:description>
<dc:creator>García Luque, A</dc:creator>
<dc:creator>Puerro Vicente, M</dc:creator>
<dc:creator>Cabanes Mariscal, M. A</dc:creator>
<dc:creator>Sánchez López, P</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Se reseñan los medicamentos ya evaluados por la Agencia Española de Medicamentos y Productos Sanitarios hechos públicos en el segundo trimestre de 2012, y considerados de mayor interés para el profesional sanitario. Se trata de opiniones técnicas positivas que son previas a la autorización y puesta en el mercado del medicamento (AU)</dc:description>
<dc:source>Sanid. mil;68(3): 177-181, jul.-sept. 2012.</dc:source>
<dc:identifier>ibc-109676</dc:identifier>
<dc:title xml:lang="es">Evaluación positiva de medicamentos: 2º Trimestre 2012</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d28622</dc:subject>
<dc:subject>^d23106</dc:subject>
<dc:subject>^d24613^s22048</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d4403^s22083</dc:subject>
<dc:type>article</dc:type>
<dc:date>201209</dc:date>
</metadata>
</record>
</ibecs-document>
